Beyond PNPLA3, several genetic variants have been implicated in the shared pathophysiology of metabolic dysfunction-associated steatotic liver disease (MASLD) and chronic kidney disease (CKD). The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.